Mitochondrial localization of human PANK2 and hypotheses of secondary iron accumulation in pantothenate kinase-associated neurodegeneration

Monique A. Johnson, Yien Ming Kuo, Shawn Westaway, Susan M. Parker, Katherine H L Ching, Jane Gitschier, Susan Hayflick

Research output: Contribution to journalArticle

74 Citations (Scopus)

Abstract

Mutations in the pantothenate kinase 2 gene (PANK2) lead to pantothenate kinase-associated neurodegeneration (PKAN, formerly Hallervorden-Spatz syndrome). This neurodegenerative disorder is characterized by iron accumulation in the basal ganglia. Pantothenate kinase is the first enzyme in the biosynthesis of coenzyme A from pantothenate (vitamin B5). PANK2, one of four human pantothenate kinase genes, is uniquely predicted to be targeted to mitochondria. We demonstrate mitochondrial localization of PANK2 and speculate on mechanisms of secondary iron accumulation in PKAN. Furthermore, PANK2 uses an unconventional translational start codon, CUG, which is polymorphic in the general population. The variant sequence, CAG (allele frequency: 0.05), leads to skipping of the mitochondrial targeting signal and cytosolic localization of PANK2. This common variant may cause mitochondrial dysfunction and impart susceptibility to late-onset neu rodegenerative disorders with brain iron accumulation, including Parkinson's disease.

Original languageEnglish (US)
Pages (from-to)282-298
Number of pages17
JournalAnnals of the New York Academy of Sciences
Volume1012
DOIs
StatePublished - 2004

Fingerprint

Pantothenate Kinase-Associated Neurodegeneration
Iron
Genes
Pantothenic Acid
Initiator Codon
Brain Diseases
Mitochondria
Coenzyme A
pantothenate kinase
Localization
Gene
Basal Ganglia
Biosynthesis
Gene Frequency
Neurodegenerative Diseases
Parkinson Disease
Brain
Mutation

Keywords

  • Brain iron
  • CoA
  • Hallervorden-Spatz syndrome
  • Mitochondrial localization
  • Pantothenate kinase
  • PKAN

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Mitochondrial localization of human PANK2 and hypotheses of secondary iron accumulation in pantothenate kinase-associated neurodegeneration. / Johnson, Monique A.; Kuo, Yien Ming; Westaway, Shawn; Parker, Susan M.; Ching, Katherine H L; Gitschier, Jane; Hayflick, Susan.

In: Annals of the New York Academy of Sciences, Vol. 1012, 2004, p. 282-298.

Research output: Contribution to journalArticle

@article{9bb73187927e4e65863f31085e861790,
title = "Mitochondrial localization of human PANK2 and hypotheses of secondary iron accumulation in pantothenate kinase-associated neurodegeneration",
abstract = "Mutations in the pantothenate kinase 2 gene (PANK2) lead to pantothenate kinase-associated neurodegeneration (PKAN, formerly Hallervorden-Spatz syndrome). This neurodegenerative disorder is characterized by iron accumulation in the basal ganglia. Pantothenate kinase is the first enzyme in the biosynthesis of coenzyme A from pantothenate (vitamin B5). PANK2, one of four human pantothenate kinase genes, is uniquely predicted to be targeted to mitochondria. We demonstrate mitochondrial localization of PANK2 and speculate on mechanisms of secondary iron accumulation in PKAN. Furthermore, PANK2 uses an unconventional translational start codon, CUG, which is polymorphic in the general population. The variant sequence, CAG (allele frequency: 0.05), leads to skipping of the mitochondrial targeting signal and cytosolic localization of PANK2. This common variant may cause mitochondrial dysfunction and impart susceptibility to late-onset neu rodegenerative disorders with brain iron accumulation, including Parkinson's disease.",
keywords = "Brain iron, CoA, Hallervorden-Spatz syndrome, Mitochondrial localization, Pantothenate kinase, PKAN",
author = "Johnson, {Monique A.} and Kuo, {Yien Ming} and Shawn Westaway and Parker, {Susan M.} and Ching, {Katherine H L} and Jane Gitschier and Susan Hayflick",
year = "2004",
doi = "10.1196/annals.1306.023",
language = "English (US)",
volume = "1012",
pages = "282--298",
journal = "Annals of the New York Academy of Sciences",
issn = "0077-8923",
publisher = "Wiley-Blackwell",

}

TY - JOUR

T1 - Mitochondrial localization of human PANK2 and hypotheses of secondary iron accumulation in pantothenate kinase-associated neurodegeneration

AU - Johnson, Monique A.

AU - Kuo, Yien Ming

AU - Westaway, Shawn

AU - Parker, Susan M.

AU - Ching, Katherine H L

AU - Gitschier, Jane

AU - Hayflick, Susan

PY - 2004

Y1 - 2004

N2 - Mutations in the pantothenate kinase 2 gene (PANK2) lead to pantothenate kinase-associated neurodegeneration (PKAN, formerly Hallervorden-Spatz syndrome). This neurodegenerative disorder is characterized by iron accumulation in the basal ganglia. Pantothenate kinase is the first enzyme in the biosynthesis of coenzyme A from pantothenate (vitamin B5). PANK2, one of four human pantothenate kinase genes, is uniquely predicted to be targeted to mitochondria. We demonstrate mitochondrial localization of PANK2 and speculate on mechanisms of secondary iron accumulation in PKAN. Furthermore, PANK2 uses an unconventional translational start codon, CUG, which is polymorphic in the general population. The variant sequence, CAG (allele frequency: 0.05), leads to skipping of the mitochondrial targeting signal and cytosolic localization of PANK2. This common variant may cause mitochondrial dysfunction and impart susceptibility to late-onset neu rodegenerative disorders with brain iron accumulation, including Parkinson's disease.

AB - Mutations in the pantothenate kinase 2 gene (PANK2) lead to pantothenate kinase-associated neurodegeneration (PKAN, formerly Hallervorden-Spatz syndrome). This neurodegenerative disorder is characterized by iron accumulation in the basal ganglia. Pantothenate kinase is the first enzyme in the biosynthesis of coenzyme A from pantothenate (vitamin B5). PANK2, one of four human pantothenate kinase genes, is uniquely predicted to be targeted to mitochondria. We demonstrate mitochondrial localization of PANK2 and speculate on mechanisms of secondary iron accumulation in PKAN. Furthermore, PANK2 uses an unconventional translational start codon, CUG, which is polymorphic in the general population. The variant sequence, CAG (allele frequency: 0.05), leads to skipping of the mitochondrial targeting signal and cytosolic localization of PANK2. This common variant may cause mitochondrial dysfunction and impart susceptibility to late-onset neu rodegenerative disorders with brain iron accumulation, including Parkinson's disease.

KW - Brain iron

KW - CoA

KW - Hallervorden-Spatz syndrome

KW - Mitochondrial localization

KW - Pantothenate kinase

KW - PKAN

UR - http://www.scopus.com/inward/record.url?scp=1842504252&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=1842504252&partnerID=8YFLogxK

U2 - 10.1196/annals.1306.023

DO - 10.1196/annals.1306.023

M3 - Article

C2 - 15105273

AN - SCOPUS:1842504252

VL - 1012

SP - 282

EP - 298

JO - Annals of the New York Academy of Sciences

JF - Annals of the New York Academy of Sciences

SN - 0077-8923

ER -